Michael S. Lee, M.D.
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2009 | Duke University School of Medicine, Durham, NC, USA, MD, Medicine |
| 2005 | Johns Hopkins University, Baltimore, MD, USA, BS, Biomedical Engineering |
Board Certifications
| 2015 | American Board of Medical Oncology, Medical Oncology |
| 2015 | American Board of Medical Oncology, Hematology |
| 2012 | American Board of Internal Medicine, Internal Medicine |
Grant & Contract Support
| Title: | 2021-0854, An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination with Belzutifan in Multiple Solid Tumors |
| Funding Source: | Merck |
| Role: | Principal Investigator |